[Seite 76↓]


Lehrbücher und Nachschlagewerke:

Baenkler H: Medizinische Immunologie - Grundlagen, Diagnostik, Klinik, Therapie, Prophylaxe, Sonderbereiche.ecomed, Landsberg 1995.

Brooks GF, Butel JS, Morse SA: Jawetz, Melnick, & Adelberg’s Medical Microbiology, 22. Auflage.Appleton & Lange, Stamford 2001.

Burmester GR, Pezzutto A: Taschenatlas der Immunologie. Grundlagen, Labor, Klinik.Thieme Verlag, Stuttgart 1998.

Janeway CA, Travers P: Immunobiology. The Immune System in Health and Disease, 5. Auflage.Garland Press, New York 2001.

Peter HH, Pichler WJ: Klinische Immunologie, 2.Auflage.Urban & Schwarzenberg, München 1996.

Radbruch A: Flow Cytometry and Cell sorting, 2. Auflage.Springer Verlag, Heidelberg 2000.

Artikel aus Fachzeitschriften:

Abbas AK et al.: Functional diversity of helper T lymphocytes. Nature 1996; 383: 787-793.

Allegretta M et al.: T cells responsive to myelin basic protein in patients with multiple sclerosis.Science 1990; 247: 718-21.

Alter M et al.: Risk of multiple sclerosis related to age at immigration to Israel.Archives of Neurology 1966; 15: 234-7.

[Seite 77↓]

Altman JD et al.: Phenotypic analysis of antigen-specific T lymphocytes.Science 1996; 274: 94-6.

Becher B et al.: Interferon- γ secretion by peripheral blood T-cell subsets in multiple sclerosis: Correlation with disease phase and Interferon- β therapy.Annals of Neurology 1999; 45: 247-50.

Beck J et al.: Increased production of interferon gamma and tumor necrosis factor precedes clinical manifestation in multiple sclerosis: Do cytokines trigger off exacerbations? Acta Neurologica Scandinavica 1988; 78: 318-23.

Ben-Nun A et al.: Vaccination against autoimmune encephalomyelitis with T-lymphocite line cells reactive against myelin basic protein.Nature 1981; 292(5818): 60-1.

Bernard CCA et al.: Myelin oligodendrocyte glycoprotein: a novel candidate autoantigen in multiple sclerosis.Journal of Molecular Medicine 1997; 75: 77-88.

Bieganowska KD et al.: Direct Ex Vivo Analysis of activated, Fas-sensitive autoreactive T cells in human autoimmune disease. Journal of Experimental Medicine 1997; 185(9): 1585-94.

Bielekova B et al.: Preferential expansion of autoreactive T lymphocytes from the memory T-cell pool by IL-7.Journal of Neuroimmunology 1999; 100: 115-23.

Bielekova B et al.: Encephalitogenic potential of the myelin basic protein peptide (amino acids 83-99) in multiple sclerosis: results of a phase II clinical trial with an altered peptide ligand.Nature Medicine 2000; 6(10): 1167-75.

Brosterhus H et al.: Enrichment and detection of live antigen-specific CD4+ and CD8+ T cells based on cytokine secretion.European Journal of Immunology 1999; 29: 4053-9.

Burns J et al.: Isolation of myelin basic protein-specific T cells predominantly from the memory T-cell compartment in multiple sclerosis. Annals of Neurology 1999; 45: 33-9.

[Seite 78↓]

Chou YK et al.: Frequency of T cells specific for myelin basic protein and proteolipid protein in blood and cerebrospinal fluid in multiple sclerosis.Journal of Neuroimmunology 1992; 38: 105-14.

Comabella M et al.: Elevated Interleukin-12 in progressive multiple sclerosis correlates with disease activity and is normalized by pulse cyclophosphamide therapy.Journal of Clinical Investigation 1998; 102: 671-8.

Dore-Duffy P et al.: Expression of endothelial cell activation antigens in microvessels from patients with multiple sclerosis.Advances in Experimental Medicine and Biology 1993; 331: 243-8.

Durán I et al.: Similar pro- and anti-inflammatory cytokine production in the different clinical forms of multiple sclerosis.Multiple Sclerosis 2001; 7: 151-6.

Ebers GC et al.: The role of genetic factors of multiple sclerosis susceptibility.Journal of Neuroimmunology 1994; 54: 1-17.

Eming R et al.: Frequency analysis of autoreactive T-helper 1 and 2 cells in bullous pemphigoid and pemphigus vulgaris by enzyme-linked immunospot assay.British Journal of Dermatology 2000; 143: 1279-82.

Eylar, EH: Encephalitogenic basic protein (EBP).Neurosciences Research Program Bulletin 1971; 9: 545-6.

Gran B et al.: Mechanisms of immunomodulation by glatiramer acetate.Neurology 2000; 55: 1704-14.

Hellings N et al.: T-cell reactivity to multiple myelin antigens in multiple sclerosis patients and healthy controls.Journal of Neuroscience Research 2001; 63: 290-302.

Helms T et al.: Direct visualization of cytokine-producing recall antigen-specific CD4 memory T cells in healthy individuals and HIV patients.Journal of Immunology 2000; 164: 3723-32.

[Seite 79↓]

Hofman FM et al.: Tumor necrosis factor identified in multiple sclerosis brain.Journal of Experimental Medicine 1989; 170: 607-12.

Hohlfeld R et al.: The role of autoimmune T lymphocytes in the pathogenesis of multiple sclerosis.Neurology 1995; 45(Suppl 6): 33-38.

Kappos L et al.: Induction of a non-encephalogenic type 2 T helper-cell autoimmune response in multiple sclerosis after administration of an altered peptide ligand in a placebo-controlled, randomised phase II trial.Nature Medicine 2000; 6(10): 1176-82.

Kelso A: Th1 and Th2 subsets: paradigms lost? Immunology Today 1995; 16(8): 374-9.

Kurtzke JF: Rating neurologic impairment in multiple sclerosis: An expanded disability status scale (EDSS).Neurology 1983; 33: 1444-1452.

Kuzushima K et al.: Rapid determination of Epstein-Barr virus-specific CD8+ T-cell frequencies by flow cytometry.Blood 1999; 94(9): 3094-100.

Lassmann H et al.: Are current immunological concepts of multiple sclerosis reflected by the immunopathology of its lesions? Springer Seminars in Immunopathology 1995; 17: 77-87.

Link H et al.: Virus-reactive and autoreactive T cells are accumulated in cerebrospinal fluid in multiple sclerosis.Journal of Neuroimmunology 1992; 38: 63-74.

Lodge PA et al.: Frequency of MBP and MBP peptide-reactive T cells in the HPRT mutant T-cell population of MS patients.Neurology 1996; 46: 1410-5.

Lovett-Racke AE et al.: Decreased dependence of myelin basic protein-reactive T cells on CD28-mediated costimulation in multiple sclerosis patients.Journal of Clinical Investigation 1998; 101: 725-30.

[Seite 80↓]

Lucchinetti CF et al.: Distinct patterns of multiple sclerosis pathology indicates heterogeneity in pathogenesis.Brain Pathology 1996; 6: 259-74.

Lucchinetti CF et al.: Heterogeneity of multiple sclerosis lesions: Implications for the pathogenesis of demyelination.Annals of Neurology 2000; 47: 707-17.

Ludwin SK: Understanding multiple sclerosis: Lessons from pathology.Annals of Neurology 2000; 47: 691-3.

Maggi E et al.: Accumulation of Th-2-like helper T cells in the conjunctiva of patients with vernal conjunctivitis.Journal of Immunology 1991; 146(4): 1169-74.

Manz R et al.: Analysis and sorting of live cells according to secreted molecules, relocated to a cell-surface affinity matrix.Proceedings of the National Academy of Sciences of the United States of America 1995; 92: 1921-5.

Martin R et al.: T helper cell differentiation in multiple sclerosis and autoimmunity.Immunology Today, 1998; 19(11): 495-98.

Martin VM et al.: Immunomagnetic enrichment of disseminated epithelial tumor cells from peripheral blood by MACS.Experimental Hematology 1998; 26(3): 252-64.

Martino G et al.: Immunopathogenesis of multiple sclerosis: The role of T cells.Opinions in Neurology 1999; 12: 309-21.

McCutcheon M et al.: A sensitive ELISPOT assay to detect low-frequency human T lymphocytes.Journal of Immunological Methods 1997; 210: 149-66.

Miller DM et al.: A meta-analysis of methylprednisolone in recovery from multiple sclerosis exacerbations.Multiple Sclerosis 2000; 6: 267-73.

[Seite 81↓]

Miltenyi S et al.: High gradient cell sorting with MACS.Cytometry 1990; 11: 231-8.

Morahan G et al.: Linkage disequilibrium of a type 1 diabetes susceptibility locus with a regulatory IL12B allele.Nature Genetics 2001; 27(2): 218-21.

Mosmann TR et al.: Two types of murine helper T cell clone. I. Definition according to profiles of lymphokine activities and secreted proteins.Journal of Immunology 1986; 136(7): 2348-57.

Muraro P et al.: Human autoreactive CD4+ T cells from naïve CD45RA+ and memory CD45RO+ subsets differ with respect to epitope specifity and functional antigen avidity.Journal of Immunology 2000; 164: 5474-81.

Myhr KM et al.: Altered antibody pattern to Epstein-Barr virus but not to other herpesviruses in multiple sclerosis: a population based case-control study from western Norway.Journal of Neurology, Neurosurgery and Psychiatry 1998; 64: 539-42.

Neuhaus O et al.: Mechanisms of action of glatiramer acetate in multiple sclerosis.Neurology 2001; 56: 702-8.

Nomura et al.: Optimization of whole blood antigen-specific cytokine assays for CD4+ T cells.Cytometry 2000; 40: 60-68.

O’Shea JJ et al.: Cytokines and autoimmunity.Nature Reviews Immunology 2002; 2: 37-45.

Olsson T et al.(1): Antimyelin basic protein and antimyelin antibody-producing cells in multiple sclerosis.Annals of Neurology 1990; 27: 132-6.

Olsson T et al.(2): Autoreactive T lymphocytes in multiple sclerosis determined by antigen-induced secretion of Interferon- γ.Journal of Clinical Investigation 1990; 86: 981-5.

Olsson T: Cerebrospinal Fluid.Annals of Neurology 1994; 36: 100-102.

[Seite 82↓]

Palace J et al.: New treatments and azathioprine in multiple sclerosis.Lancet 1997; 350(9073): 261.

Pelfrey CM et al.: Two mechanisms of antigen-specific apoptosis of myelin basic protein (MBP)-specific T lymphocytes derived from multiple sclerosis patients and normal individuals. Journal of Immunology 1995; 154: 6191-202.

Petry KG et al.: Experimental allergic encephalomyelitis animal models for analysing features of multiple sclerosis.Pathologie Biologie 2000; 48: 47-53.

Pettinelli CB et al.: Adoptive transfer of experimental allergic encephalomyelitis in SJL/J mice after in vivo activation of lymph node cells by myelin basic protein: requirement for Lyt 1+ 2- T lymphocytes.Journal of Immunology 1981; 127(4): 1420-3.

Poser CM et al.: New diagnostic criteria for multiple sclerosis : Guidelines for research protocols.Annals of Neurology 1983; 13(3): 227-231.

Poser CM et al.: Diagnostic criteria for multiple sclerosis.Clinical Neurology and Neurosurgery 2001; 103: 1-11.

Prussin C: Cytokine flow cytometry: Understanding cytokine biology at the single-cell level.Journal of Clinical Investigation 1997; 17(3): 195-204.

Rohowsky-Kochan C et al.: Cytokine secretion profile of myelin basic protein-specific T cells in multiple sclerosis.Multiple Sclerosis 2000; 6: 69-77.

Romagnani S: Human TH1 and TH2 subsets: doubt no more.Immunology Today 1991; 12(8): 256-7.

Russell JH: Activation-induced death of mature T cells in the regulation of immune responses.Current Opinion in Immunology 1995; 7: 382-8.

Sadovnik AD et al.: A population-based study of multiple sclerosis in twins: Update.Annals of Neurology 1993; 33: 281-5.

[Seite 83↓]

Schmidt S: Candidate autoantigens in multiple sclerosis.Multiple Sclerosis 1999; 5: 147-60.

Scholz C et al.: Expansion of autoreactive T cells in Multiple Sclerosis is independent of exogenous B7 costimulation.Journal of Immunology 1998; 160: 1532-8.

Sharief MK et al.: In vivo relationship of tumor necrosis factor- α to blood-brain barrier damage in patients with active multiple sclerosis.Journal of Neuroimmunology 1992; 38: 27-34.

Sherrit et al.: Influence of HLA-DR2, HLA-DPw4, and T cell receptor α chain genes on the susceptibility to multiple sclerosis.International Immunology 1992; 4(2): 177-81.

Sibley WA et al.: Clinical viral infections and multiple sclerosis.Lancet 1985; 1: 1313-15.

Simmons A: Herpesviruses and multiple sclerosis.Herpes 2001; 8(3): 60-3.

Singh VK et al.: The paradigm of Th1 and Th2 cytokines – Its relevance to autoimmunity and allergy.Immunological Research 1999; 20: 147-61.

Söderström M et al.: Autoimmune T cell repertoire in optic neuritis and multiple sclerosis : T cells recognising multiple myelin proteins are accumulated in cerebrospinal fluid.Journal of Neurology, Neurosurgery and Psychiatry 1994; 57(5): 544-51.

Stinissen P et al.: Myelin reactive T cells in the autoimmune pathogenesis of multiple sclerosis.Multiple Sclerosis 1998; 4: 203-211.

Sun JB et al.: T and B cells responding to myelin proteolipid protein in multiple sclerosis and controls.European Journal of Immunology 1991; 21: 1461-8.

Suni MA et al.: Detection of antigen-specific T cell cytokine expression in whole blood by flow cytometry.Journal of Immunological Methods 1998; 212: 89-98.

[Seite 84↓]

Tan LC et al.: A re-evaluation of the frequency of CD8+ T cells specific for EBV in healthy virus carriers.Journal of Immunology 1999; 162: 1827-35.

Tejada-Simon MV et al.: Aberrant T cell responses to myelin antigens during clinical exacerbation in patients with multiple sclerosis.International Immunology 2000; 12(12): 1641-50.

Tejada-Simon MV et al.: Reactivity pattern and cytokine profile of T cells primed by myelin peptides in multiple sclerosis and healthy individuals.European Journal of Immunology 2001; 31: 907-17.

The IFN β Multiple Sclerosis Study Group: Interferon beta-1b is effective in relapsing-remitting multiple sclerosis. Clinical results of a multicenter, randomised, double-blind, placebo-controlled trial. MRI analysis results of a multicenter, randomised, double-blind, placebo-controlled trial. Neurology 1993; 43: 655-667.

Thiel A et al.: Analysis of the antigen-specific T cell response in reactive arthritis by flow cytometry.Arthritis and Rheumatism 2000; 43(12): 2834-42.

Traugott U: Multiple sclerosis: relevance of class I and class II MHC-expressing cells to lesion development.Journal of Neuroimmunology 1987; 16(2): 283-302.

Van der Graaf WL et al.: Prognostic value of Th1/Th2 ratio in rheumatoid arthritis.Lancet 1998; 351:1931.

Van Noort JM et al.: The small heat-shock protein α B-crystallin as candidate autoantigen in multiple sclerosis.Nature 1995; 375: 798-801.

Van Oosten BW et al.: Increased production of tumor necrosis factor α , and not interferon γ , preceding disease activity in patients with multiple sclerosis.Archives of Neurology 1998; 55: 793-8.

Vandevyver C et al.: Cytokine mRNA profile of myelin basic protein reactive T-cell clones in patients with multiple sclerosis.Autoimmunity 1998; 28: 77-89.

[Seite 85↓]

Vrethem M et al.: CD4 and CD8 lymphocyte subsets in cerebrospinal fluid and peripheral blood from patients with multiple sclerosis, meningitis and normal controls.Acta Neurologica Scandinavica 1998; 97: 215-20.

Waldrop SL et al.: Determination of antigen-specific memory/effector CD4+ T cell frequencies by flow cytometry.Journal of Clinical Investigation 1997; 99: 1739-50.

Waldrop SL et al.: Normal human CD4+ memory T cells display broad heterogeneity in their activation threshold for cytokine synthesis.Journal of Immunology 1998; 161: 5284-95.

Weinshenker BG: Epidemiology of multiple sclerosis.Neuroepidemiology 1996; 14(2): 291-308.

Wekerle H: Experimental autoimmune encephalomyelitis as a model of immune-mediated CNS disease.Current opinion in Neurobiology 1993; 3: 779-84.

Wekerle H et al.: Animal models.Annals of Neurology 1994; 36: S47-S53.

Wesselborg S et al.: Induction of activation-driven death (apoptosis) in activated but not resting peripheral blood T cells.Journal of Immunology 1993; 150: 4338-45.

Woodroofe MN et al.: Cytokine mRNA expression in inflammatory multiple sclerosis lesions: Detection by non-radioactive in situ hybridisation.Cytokine 1993; 5(6): 583-8.

Yudkin PL et al.: Overview of azathioprine treatment in multiple sclerosis.Lancet 1991; 338: 1051-55.

Zang Y et al.: Impaired apoptotic deletion of myelin basic protein-reactive T cells in patients with multiple sclerosis.European Journal of Immunology 1999; 29: 1692-1700.

[Seite 86↓]

Zelenika D et al.: A new family of transcripts of the myelin basic protein gene: expression in brain and in immune system.Journal of Neurochemistry 1993; 60(4): 1574-7.

Zhang J et al.: Myelin basic protein-specific T lymphocytes in multiple sclerosis and controls: Precursor frequency, fine specifity, and cytotoxicity.Annals of Neurology 1992; 32: 330-8.

Zhang JZ et al.: T-cell vaccination in multiple sclerosis: Results of a preliminary study.Journal of Neurology 2002; 249: 212-18.

Zhang Y et al.: The T-lymphocyte response against myelin-associated glycoprotein and myelin basic protein in patients with multiple sclerosis.Neurology 1993; 43: 403-7.

Zipp F et al.: Aktuelle Empfehlungen zu Impfungen bei Multipler Sklerose.Nervenarzt 2001; 72: 802-6.

© Die inhaltliche Zusammenstellung und Aufmachung dieser Publikation sowie die elektronische Verarbeitung sind urheberrechtlich geschützt. Jede Verwertung, die nicht ausdrücklich vom Urheberrechtsgesetz zugelassen ist, bedarf der vorherigen Zustimmung. Das gilt insbesondere für die Vervielfältigung, die Bearbeitung und Einspeicherung und Verarbeitung in elektronische Systeme.
DiML DTD Version 3.0Zertifizierter Dokumentenserver
der Humboldt-Universität zu Berlin
HTML-Version erstellt am: